Hengrui medicine: shr0410 injection obtained the notice of approval for drug clinical trial
Financial Associated Press, October 28 - Hengrui pharmaceutical announced that shr0410 injection and shr8554 injection obtained the notice of approval for drug clinical trial; Shr3680 tablets are to be included in the priority review procedure.
This text is a result of machine translation.
Related companies：
In-depth
Technology
ePropulsion: Pioneering Electric Marine Propulsion for a Sustainable Future
EqualOcean recently had an insightful conversation with Mr. Tao Shizheng, the visionary founder of ePropulsion (Chinese: 逸动科技), we embarked on a journey to understand the essence of the company's profound impact on the electric marine propulsion industry.
Jan 25, 2024 02:24 PM
Briefing Feb 17, 2022 06:09 PM
· Technology
Guangdong hydropower: won the bid for the second batch of photovoltaic power generation projects in Aksu, Xinjiang in 2021
Jan 30, 2024 07:59 PM
Dec 11, 2023 08:49 PM
Jan 06, 2023 08:30 AM
Jan 05, 2023 07:33 PM
Briefing Jan 19, 2022 09:49 AM
· Consumer Staples
Baijiu stock opened lower, big lake shares limit
Briefing Dec 21, 2021 07:48 PM
· Consumer Discretionary
Taihe Group: the company's overdue loans amounted to 49.563 billion yuan
Briefing Sep 28, 2021 11:10 PM
A number of Listed Companies in Hefei are listed in the list of restricted production and high energy consuming enterprises and will face shutdown and power transfer
Briefing Aug 31, 2021 07:14 PM
Conch cement: it plans to acquire 100% equity of conch new energy company
Briefing Aug 03, 2021 08:37 AM
· Automotive
CITIC Securities: the price increase in peak season is expected in advance, and the profit stability of cement enterprises is high
See more
Read next
Insight
In-depth
Insight
In-depth